TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer.

Thatcher Ross Heumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.